Description
The webinar is focused on Why Post-market Pharmacovigilance trials are increasingly seen : What do they tell us and why are they important? In addition, attendees will understand the reasons for an increase in Post-Approval Phase IV type studies..
The webinar brings together attendees involved in the drug development process from Biotech Companies, Pharmaceutical Companies, Clinical Research sites and CROs.
